FDA grants fast track status to Erasca's ERAS-0015 for pancreatic cancer
Erasca, Inc. (Nasdaq: ERAS) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
